Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives.

The EDRN works to discover, develop and validate biomarkers and imaging methods to detect early-stage cancers, assess risk for developing cancer, and translate these tools into clinical tests.

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. 

An international team of experts, including the Uganda Cancer Institute, is developing a groundbreaking mobile breast cancer diagnostic kit to enhance early detection in Uganda, where 70% of cases are diagnosed at an advanced stage.

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.